FREE LIVE ONLINE MASTERCLASSES WITH PROF. STUART POCOCK
Real-World Evidence & Trials Masterclasses 2024-2025
If you work in RWE, Clinical Development, Market Access/HEOR, Safety or Regulatory Affairs (including EMA and FDA), in RWE and in trials, you will get a new perspective on real-world evidence studies from a trialist / statistician and epidemiologist / clinician, explained in clear non-technical terms and illustrated with examples from drugs and devices in multiple therapy areas.
Past Sessions
External Controls for Trials:
Strategy, Science, Regulators & HTAs
Discover with Prof. Stuart Pocock about perspectives on external controls for one-arm and difficult-to-enrol clinical trials.
Wednesday, 22 January 2025, at 5pm CET
COMPLETE INFO
REQUEST FOR SLIDESThe value of Hierarchical Composite Endpoints & the Win Ratio
Discover with Prof. Stuart Pocock how the Win Ratio is transforming the way we analyse outcomes in clinical trials and Real-World Evidence (RWE) studies.
Tuesday, 11 June 2024, at 5pm CEST
COMPLETE INFO
REQUEST FOR SLIDESThe speakers
STUART POCOCK
Professor of Medical Statistics, London School of Hygiene & Tropical Medicine
Author of >800 papers, including 100+NEJM/ Lancets, mainly of clinical trials and epidemiology; extensive experience of EMA/FDA and MHRA. Devised: ‘Pocock Stopping Rule’, ’Win Ratio’ for composite endpoints, and a new method for ‘Individualising Benefit-Risk’.
NAWAB QIZILBASH
Senior Clinical Epidemiologist and CMO, OXON Epidemiology
Honorary Associate Professor in Pharmacoepidemiology, London School of Hygiene & Tropical Medicine and Clinical Observer, Internal Medicine, Madrid Hospitals.
Formerly: Director, Clinical Epidemiology, GSK and Honorary Consultant Physician, Radcliffe Hospitals, Oxford